Product Overview
MEVAC™ AQUA STREPT+ is an inactivated tetravalent bacterial vaccine against Streptococcosis, Lactococcosis and Enterococcosis Disease.
You are viewing EMENA
MEVAC™ AQUA STREPT+
MEVAC™ AQUA STREPT+ is an inactivated tetravalent bacterial vaccine against Streptococcosis, Lactococcosis and Enterococcosis Disease.
Freshwater and marine water cultured fishes.
Effective vaccination in fish farms can be compromised by several factors, including failure of vaccination procedure, narrow spectrum of cross protection, and high mortalities associated with stress during fish handling, therefore it is critical for the vaccination crew to comply with good vaccination practices.1
Streptococcosis, Lactococcosis and Enterococcosis are the most frequent diseases affecting Tilapia production in many geographies worldwide. These infections are respectively caused by S. agalactiae, S. iniae, L. garvieae, and E. faecalis, particularly in regions with high temperatures.1
In general, vaccination of broodstock can confer good protection against early infection in the offspring. Tilapia offspring (approximately 0.5 g or less) relies on maternal derived antibodies, while larger fish (e.g. grow-out stage) relies on the active immunity conferred by commercially available vaccines.1
Use MEVAC™ AQUA STREPT+ to help combat dieases in your fish operation.
For vaccination and protection of commercial fish systems against Streptococcosis, Lactococcosis and Enterococcosis disease.
Fish should be vaccinated 14 days before ponding or an anticipated exposure to infection.
Zero days.
Before use, the vaccine should be shaken well to ensure proper mixing. Sterile injection equipment should be used to avoid contamination.
MEVAC™ AQUA STREPT+ is packed and presented in 500 mL (2,500 doses) polyethylene terephthalate (PET) bottles.
References
1. Abu-Elala et al (2019). Efficacy of Injectable and Immersion Polyvalent Vaccine against Streptococcal Infections in Broodstock and Offspring of Nile tilapia (Oreochromis niloticus). Fish & Shellfish Immunology, .Volume 88, May 2019, Pages 293-300.
Fill out the form below to connect with Kemin's vaccine experts.
The content on this site is intended for informational purposes only and is not intended to be a substitute for professional veterinary advice. Although the information on this site is accessible worldwide, not all products or services are available to all persons or in all geographic locations or jurisdictions. Certain statements, product labeling and claims may differ by geography or as required by local governmental regulations.
© Kemin Industries, Inc. and its group of companies all rights reserved. ® ™ Trademarks of Kemin Industries, Inc., USA
Certain statements may not be applicable in all geographical regions. Product labeling and associated claims may differ based upon government requirements.